Brokerages Set Ocular Therapeutix, Inc. (NASDAQ:OCUL) Price Target at $16.25
Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eight brokerages that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month price objective among […]
Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the eight brokerages that are presently covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month price objective among […]
